After more than 30-years with Eli Lilly and Company, former President of International Operations, Alfonso 'Chito' Zulueta takes his expertise as a senior executive of global business operations to his current role as the CEO of CZ Ventures, LLC.
AT ELI LILLY & COMPANY
Held the roles of Vice President of Global Marketing, President of Global Oncology and Critical Care, President of Lilly Japan and Emerging Markets, and President of International from 2017 until his retirement at the end of 2021. Served as an Executive Committee Member and Corporate Officer.
AS A BOARD MEMBER
Current chairman of Zuellig Pharma
Current director of the board of the following companies: Bridge PayDay, CTS Corp., Calidi Biotherapeutics, and Glooko
Previously served as a board director for Syneos Health, Amarin Corp, the European Federation of Pharmaceutical Industries and Association (EFPIA), and as Chairman of PhRMa Japan
EDUCATION
Earned a master's degree in business administration (MBA) from the University of Virginia's Darden School of Business and a bachelor's degree in Economics from De La Salle University. Participated in the inaugural Harvard Business School's Leading Global Enterprises Program and of the 2022 Stanford Director's Program.
OTHER ROLES
Received the "De La Salle Alumni Association’s LaSallian Achievement Award" for 2023
Served as Governor of the American Chamber of Commerce Japan (ACCJ) Kansai for two terms
Received the Hyogo, Japan Prefectural Award for contributions to the development of the prefecture
Associate Professor of Marketing, MBA program at De La Salle University (1990-1992). Worked as a management associate in Citibank and SGV & Company.
DIRECTOR OF THE BOARD
Bridge PayDay
Calidi Biotherapeutics
CTS Corporation
Glooko
CHAIRMAN
Zuellig Pharma
After more than 30-years with Eli Lilly and Company, former President of International Operations, Alfonso 'Chito' Zulueta takes his expertise as a senior executive of global business operations to his current role as the CEO of CZ Ventures, LLC.
AT ELI LILLY & COMPANY
Held the roles of Vice President of Global Marketing, President of Global Oncology and Critical Care, President of Lilly Japan and Emerging Markets, and President of International from 2017 until his retirement at the end of 2021. Served as an Executive Committee Member and Corporate Officer.
AS A BOARD MEMBER
Current chairman of Zuellig Pharma
Current director of the board of the following companies: Syneos Health, CTS Corp., Calidi Biotherapeutics, Glooko, Amarin Corp, and Bridge PayDay
Served as a board director of the European Federation of Pharmaceutical Industries and Association (EFPIA), and Chairman of PhRMa Japan
EDUCATION
Earned a master's degree in business administration (MBA) from the University of Virginia's Darden School of Business and a bachelor's degree in Economics from De La Salle University. Participated in the inaugural Harvard Business School's Leading Global Enterprises Program and of the 2022 Stanford Director's Program.
OTHER ROLES
Received the "De La Salle Alumni Association’s LaSallian Achievement Award" for 2023
Received the Hyogo, Japan Prefectural Award for contributions to the development of the prefecture
Served as Governor of the American Chamber of Commerce Japan (ACCJ) Kansai for two terms
Associate Professor of Marketing, MBA program at De La Salle University (1990-1992). Worked as a management associate in Citibank and SGV & Company.
FOUNDED BY
Alfonso 'Chito' Zulueta